organization · Reporting owner
K/I/E Trust Under Agreement 10/24/18
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NRC HEALTHNRC · Entity 5534 | 10% owner | March 11, 2021 | March 15, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NRC HEALTH
Report date March 11, 2021 · Filed March 15, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-03-11 transaction · row 1
1 source rowRow 1 · 2021-03-11 · Sale · Disposed 4,751,522 · Balance 0 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 11, 2021 Filed Mar 15, 2021 20:34 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 4,751,522 | $51.00 | $242,327,622.00 |
DisclosureSEC source: 0001567619-21-006311 · doc1.xml · nonDerivative · entry 1 K/I/E Trust Under Agreement 10/24/18 · CIK 0001579448 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| May 08, 2019 Filed May 9, 2019 22:57 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 185,088 | $40.00 | $7,403,668.07 |
DisclosureSEC source: 0001567619-19-010321 · doc1.xml · nonDerivative · entry 1 K/I/E Trust Under Agreement 10/24/18 · CIK 0001579448 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,755,013 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. F2 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $40.00 to $40.13. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| May 07, 2019 Filed May 7, 2019 21:32 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 30,312 | $40.00 | $1,212,504.25 |
DisclosureSEC source: 0001567619-19-010045 · doc1.xml · nonDerivative · entry 2 K/I/E Trust Under Agreement 10/24/18 · CIK 0001579448 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,940,101 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. F3 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $40.00 to $40.13. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| May 06, 2019 Filed May 7, 2019 21:32 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 18,954 | $40.02 | $758,474.64 |
DisclosureSEC source: 0001567619-19-010045 · doc1.xml · nonDerivative · entry 1 K/I/E Trust Under Agreement 10/24/18 · CIK 0001579448 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,970,413 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. F2 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $40.00 to $40.05. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| May 03, 2019 Filed May 6, 2019 15:14 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 29,378 | $40.00 | $1,175,152.32 |
DisclosureSEC source: 0001567619-19-009800 · doc1.xml · nonDerivative · entry 1 K/I/E Trust Under Agreement 10/24/18 · CIK 0001579448 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,989,367 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. F2 · price: The price in Column 4 is a weighted average prices. The prices actually received ranged from $40.00 to $40.065. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| May 01, 2019 Filed May 2, 2019 15:19 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 1,479 | $40.01 | $59,169.02 |
DisclosureSEC source: 0001567619-19-009606 · doc1.xml · nonDerivative · entry 1 K/I/E Trust Under Agreement 10/24/18 · CIK 0001579448 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,018,745 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. F2 · price: The price in Column 4 is a weighted average prices. The prices actually received ranged from $40.00 to $40.04. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| April 24, 2019 Filed Apr 25, 2019 21:05 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 1,532 | $40.00 | $61,280.00 |
DisclosureSEC source: 0001567619-19-009200 · doc1.xml · nonDerivative · entry 1 K/I/E Trust Under Agreement 10/24/18 · CIK 0001579448 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,020,224 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. Read SEC document |
| April 23, 2019 Filed Apr 24, 2019 13:19 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 2,702 | $40.01 | $108,108.64 |
DisclosureSEC source: 0001567619-19-009080 · doc1.xml · nonDerivative · entry 1 K/I/E Trust Under Agreement 10/24/18 · CIK 0001579448 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,021,756 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. F2 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $40.00 to $40.035. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| April 16, 2019 Filed Apr 17, 2019 14:53 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 7,950 | $40.01 | $318,048.50 |
DisclosureSEC source: 0001567619-19-008872 · doc1.xml · nonDerivative · entry 1 K/I/E Trust Under Agreement 10/24/18 · CIK 0001579448 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,024,458 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. F2 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $40.00 to $40.05. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| April 12, 2019 Filed Apr 12, 2019 21:01 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 3,539 | $40.00 | $141,560.00 |
DisclosureSEC source: 0001567619-19-008750 · doc1.xml · nonDerivative · entry 1 K/I/E Trust Under Agreement 10/24/18 · CIK 0001579448 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,032,408 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. Read SEC document |
| April 11, 2019 Filed Apr 12, 2019 15:47 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 1,106 | $40.00 | $44,240.00 |
DisclosureSEC source: 0001567619-19-008722 · doc1.xml · nonDerivative · entry 1 K/I/E Trust Under Agreement 10/24/18 · CIK 0001579448 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,035,947 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. Read SEC document |
| March 21, 2019 Filed Mar 22, 2019 21:43 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 1,300 | $40.00 | $52,001.04 |
DisclosureSEC source: 0001567619-19-007498 · doc1.xml · nonDerivative · entry 1 K/I/E Trust Under Agreement 10/24/18 · CIK 0001579448 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,037,053 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. F2 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $40.00 to $40.01. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| March 20, 2019 Filed Mar 21, 2019 14:48 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 1,352 | $40.00 | $54,081.62 |
DisclosureSEC source: 0001567619-19-007334 · doc1.xml · nonDerivative · entry 2 K/I/E Trust Under Agreement 10/24/18 · CIK 0001579448 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,038,353 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. F3 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $40.00 to $40.02. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| March 19, 2019 Filed Mar 21, 2019 14:48 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 3,455 | $40.01 | $138,239.04 |
DisclosureSEC source: 0001567619-19-007334 · doc1.xml · nonDerivative · entry 1 K/I/E Trust Under Agreement 10/24/18 · CIK 0001579448 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,039,705 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. F2 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $40.00 to $40.045. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| March 14, 2019 Filed Mar 14, 2019 21:04 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 1,022 | $40.00 | $40,880.00 |
DisclosureSEC source: 0001567619-19-006884 · doc1.xml · nonDerivative · entry 2 K/I/E Trust Under Agreement 10/24/18 · CIK 0001579448 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,043,160 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. Read SEC document |
| March 13, 2019 Filed Mar 14, 2019 21:04 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 5,641 | $40.00 | $225,658.62 |
DisclosureSEC source: 0001567619-19-006884 · doc1.xml · nonDerivative · entry 1 K/I/E Trust Under Agreement 10/24/18 · CIK 0001579448 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,044,182 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. F2 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $40.00 to $40.075. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| March 12, 2019 Filed Mar 13, 2019 14:24 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 9,102 | $40.00 | $364,080.00 |
DisclosureSEC source: 0001567619-19-006768 · doc1.xml · nonDerivative · entry 2 K/I/E Trust Under Agreement 10/24/18 · CIK 0001579448 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,049,823 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. Read SEC document |
| March 11, 2019 Filed Mar 13, 2019 14:24 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 1,416 | $40.00 | $56,640.00 |
DisclosureSEC source: 0001567619-19-006768 · doc1.xml · nonDerivative · entry 1 K/I/E Trust Under Agreement 10/24/18 · CIK 0001579448 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,058,925 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. Read SEC document |
| February 22, 2019 Filed Feb 26, 2019 20:51 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 6,696 | $40.01 | $267,894.91 |
DisclosureSEC source: 0001567619-19-005410 · doc1.xml · nonDerivative · entry 1 K/I/E Trust Under Agreement 10/24/18 · CIK 0001579448 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,060,341 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. F2 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $40.00 to $40.075. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| February 20, 2019 Filed Feb 21, 2019 14:52 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 9,253 | $40.06 | $370,638.17 |
DisclosureSEC source: 0001567619-19-005054 · doc1.xml · nonDerivative · entry 2 K/I/E Trust Under Agreement 10/24/18 · CIK 0001579448 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,067,037 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. F3 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $40.00 to $40.195. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 14:52 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 79,772 | $40.00 | $3,190,903.93 |
DisclosureSEC source: 0001567619-19-005054 · doc1.xml · nonDerivative · entry 1 K/I/E Trust Under Agreement 10/24/18 · CIK 0001579448 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,076,290 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. F2 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $40.00 to $40.18. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 15:49 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 11,848 | $40.04 | $474,340.60 |
DisclosureSEC source: 0001567619-19-004766 · doc1.xml · nonDerivative · entry 1 K/I/E Trust Under Agreement 10/24/18 · CIK 0001579448 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,156,062 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. F2 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $40.00 to $40.15. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| January 31, 2019 Filed Feb 4, 2019 18:05 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 2,073 | $40.01 | $82,940.94 |
DisclosureSEC source: 0001567619-19-002220 · doc1.xml · nonDerivative · entry 1 K/I/E Trust Under Agreement 10/24/18 · CIK 0001579448 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,167,910 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. F2 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $40.00 to $40.07. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| January 25, 2019 Filed Jan 28, 2019 20:45 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 5,582 | $40.01 | $223,353.12 |
DisclosureSEC source: 0001567619-19-001770 · doc1.xml · nonDerivative · entry 2 K/I/E Trust Under Agreement 10/24/18 · CIK 0001579448 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,169,983 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. F3 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $40.00 to $40.14. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| January 24, 2019 Filed Jan 28, 2019 20:45 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 4,148 | $40.00 | $165,936.59 |
DisclosureSEC source: 0001567619-19-001770 · doc1.xml · nonDerivative · entry 1 K/I/E Trust Under Agreement 10/24/18 · CIK 0001579448 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,175,565 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. F2 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $40.00 to $40.025. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| January 23, 2019 Filed Jan 24, 2019 14:13 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 25,205 | $40.00 | $1,008,250.41 |
DisclosureSEC source: 0001567619-19-001524 · doc1.xml · nonDerivative · entry 2 K/I/E/Trust Under Agreement 3/9/09 · CIK 0001579448 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,179,713 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. F3 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $40.00 to $40.105. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 14:13 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 12,355 | $40.00 | $494,214.83 |
DisclosureSEC source: 0001567619-19-001524 · doc1.xml · nonDerivative · entry 1 K/I/E/Trust Under Agreement 3/9/09 · CIK 0001579448 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,204,918 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. F2 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $40.00 to $40.15. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| January 18, 2019 Filed Jan 22, 2019 23:11 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 147,693 | $40.07 | $5,918,560.67 |
DisclosureSEC source: 0001567619-19-001456 · doc1.xml · nonDerivative · entry 1 K/I/E/Trust Under Agreement 3/9/09 · CIK 0001579448 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,217,273 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. F2 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $40.00 to $40.075. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| December 17, 2018 Filed Dec 18, 2018 18:00 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 1,359 | $40.00 | $54,360.00 |
DisclosureSEC source: 0001567619-18-008183 · doc1.xml · nonDerivative · entry 1 K/I/E/Trust Under Agreement 3/9/09 · CIK 0001579448 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,364,966 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. F1 · price: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. Read SEC document |
| December 13, 2018 Filed Dec 17, 2018 16:27 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 2,013 | $40.00 | $80,520.00 |
DisclosureSEC source: 0001567619-18-008085 · doc1.xml · nonDerivative · entry 1 K/I/E/Trust Under Agreement 3/9/09 · CIK 0001579448 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,366,325 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. Read SEC document |
| December 12, 2018 Filed Dec 13, 2018 17:42 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 4,406 | $40.00 | $176,244.85 |
DisclosureSEC source: 0001567619-18-007833 · doc1.xml · nonDerivative · entry 1 K/I/E/Trust Under Agreement 3/9/09 · CIK 0001579448 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,368,338 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. F2 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $40.00 to $40.04. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| November 29, 2018 Filed Dec 3, 2018 17:08 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 4,441 | $40.01 | $177,698.62 |
DisclosureSEC source: 0001567619-18-007210 · doc1.xml · nonDerivative · entry 1 K/I/E/Trust Under Agreement 3/9/09 · CIK 0001579448 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,372,744 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. F2 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $40.00 to $40.065. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| November 28, 2018 Filed Nov 29, 2018 15:44 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 2,640 | $40.00 | $105,600.00 |
DisclosureSEC source: 0001567619-18-007086 · doc1.xml · nonDerivative · entry 1 K/I/E/Trust Under Agreement 3/9/09 · CIK 0001579448 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,377,185 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. Read SEC document |
| November 12, 2018 Filed Nov 13, 2018 15:33 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 2,173 | $40.00 | $86,920.00 |
DisclosureSEC source: 0001567619-18-005663 · doc1.xml · nonDerivative · entry 1 K/I/E/Trust Under Agreement 3/9/09 · CIK 0001579448 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,379,825 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. Read SEC document |
| September 18, 2018 Filed Sep 19, 2018 20:47 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 1,451 | $40.00 | $58,040.00 |
DisclosureSEC source: 0001567619-18-002894 · doc1.xml · nonDerivative · entry 1 K/I/E/Trust Under Agreement 3/9/09 · CIK 0001579448 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,381,998 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. Read SEC document |
| August 27, 2018 Filed Aug 28, 2018 22:21 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 5,185 | $40.00 | $207,400.00 |
DisclosureSEC source: 0001567619-18-001856 · doc1.xml · nonDerivative · entry 2 K/I/E/Trust Under Agreement 3/9/09 · CIK 0001579448 · 10% owner Endacott Kent E. · CIK 0001579075 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,383,449 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. Read SEC document |
| August 24, 2018 Filed Aug 28, 2018 22:21 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 9,300 | $40.00 | $372,000.00 |
DisclosureSEC source: 0001567619-18-001856 · doc1.xml · nonDerivative · entry 1 K/I/E/Trust Under Agreement 3/9/09 · CIK 0001579448 · 10% owner Endacott Kent E. · CIK 0001579075 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,388,634 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. Read SEC document |
| August 23, 2018 Filed Aug 23, 2018 21:35 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 107 | $41.33 | $4,421.78 |
DisclosureSEC source: 0001567619-18-001747 · doc1.xml · nonDerivative · entry 3 K/I/E/Trust Under Agreement 3/9/09 · CIK 0001579448 · 10% owner Endacott Kent E. · CIK 0001579075 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,397,934 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. Read SEC document |
| August 23, 2018 Filed Aug 23, 2018 21:35 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 10,972 | $40.01 | $438,960.10 |
DisclosureSEC source: 0001567619-18-001747 · doc1.xml · nonDerivative · entry 2 K/I/E/Trust Under Agreement 3/9/09 · CIK 0001579448 · 10% owner Endacott Kent E. · CIK 0001579075 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,398,041 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. F2 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $40.00 to $40.40. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| August 22, 2018 Filed Aug 23, 2018 21:35 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 150,670 | $38.00 | $5,725,460.00 |
DisclosureSEC source: 0001567619-18-001747 · doc1.xml · nonDerivative · entry 1 K/I/E/Trust Under Agreement 3/9/09 · CIK 0001579448 · 10% owner Endacott Kent E. · CIK 0001579075 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,409,013 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. Read SEC document |
| August 21, 2018 Filed Aug 21, 2018 22:22 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 26,535 | $38.05 | $1,009,553.26 |
DisclosureSEC source: 0001567619-18-001586 · doc1.xml · nonDerivative · entry 3 K/I/E/Trust Under Agreement 3/9/09 · CIK 0001579448 · 10% owner Endacott Kent E. · CIK 0001579075 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,559,683 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. F3 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $38.00 to $38.15. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| August 20, 2018 Filed Aug 21, 2018 22:22 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 7,416 | $38.01 | $281,848.05 |
DisclosureSEC source: 0001567619-18-001586 · doc1.xml · nonDerivative · entry 2 K/I/E/Trust Under Agreement 3/9/09 · CIK 0001579448 · 10% owner Endacott Kent E. · CIK 0001579075 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,586,218 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. F2 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $38.00 to $38.05. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| August 17, 2018 Filed Aug 21, 2018 22:22 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 4,529 | $38.00 | $172,102.00 |
DisclosureSEC source: 0001567619-18-001586 · doc1.xml · nonDerivative · entry 1 K/I/E/Trust Under Agreement 3/9/09 · CIK 0001579448 · 10% owner Endacott Kent E. · CIK 0001579075 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,593,634 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. Read SEC document |
| August 14, 2018 Filed Aug 15, 2018 23:21 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 4,187 | $38.00 | $159,118.98 |
DisclosureSEC source: 0001567619-18-001230 · doc1.xml · nonDerivative · entry 2 K/I/E/Trust Under Agreement 3/9/09 · CIK 0001579448 · 10% owner Endacott Kent E. · CIK 0001579075 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,598,163 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. F3 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $38.00 to $38.075. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| August 13, 2018 Filed Aug 15, 2018 23:21 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 37,206 | $38.05 | $1,415,781.32 |
DisclosureSEC source: 0001567619-18-001230 · doc1.xml · nonDerivative · entry 1 K/I/E/Trust Under Agreement 3/9/09 · CIK 0001579448 · 10% owner Endacott Kent E. · CIK 0001579075 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,602,350 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. F2 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $38.00 to $38.15. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| August 10, 2018 Filed Aug 13, 2018 21:34 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 1,756 | $38.00 | $66,728.00 |
DisclosureSEC source: 0001567619-18-000656 · doc1.xml · nonDerivative · entry 2 K/I/E/Trust Under Agreement 3/9/09 · CIK 0001579448 · 10% owner Endacott Kent E. · CIK 0001579075 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,639,556 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. Read SEC document |
| August 09, 2018 Filed Aug 13, 2018 21:34 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 2,608 | $38.00 | $99,104.00 |
DisclosureSEC source: 0001567619-18-000656 · doc1.xml · nonDerivative · entry 1 K/I/E/Trust Under Agreement 3/9/09 · CIK 0001579448 · 10% owner Endacott Kent E. · CIK 0001579075 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,641,312 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. Read SEC document |
| August 08, 2018 Filed Aug 8, 2018 21:57 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 12,745 | $38.00 | $484,340.59 |
DisclosureSEC source: 0001567619-18-000163 · doc1.xml · nonDerivative · entry 3 K/I/E/Trust Under Agreement 3/9/09 · CIK 0001579448 · 10% owner Endacott Kent E. · CIK 0001579075 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,643,920 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. F2 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $38.00 to $38.05. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| August 07, 2018 Filed Aug 8, 2018 21:57 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 23,457 | $38.00 | $891,377.73 |
DisclosureSEC source: 0001567619-18-000163 · doc1.xml · nonDerivative · entry 2 K/I/E/Trust Under Agreement 3/9/09 · CIK 0001579448 · 10% owner Endacott Kent E. · CIK 0001579075 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,656,665 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. F2 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $38.00 to $38.05. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| August 06, 2018 Filed Aug 8, 2018 21:57 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 20,132 | $38.00 | $765,016.00 |
DisclosureSEC source: 0001567619-18-000163 · doc1.xml · nonDerivative · entry 1 K/I/E/Trust Under Agreement 3/9/09 · CIK 0001579448 · 10% owner Endacott Kent E. · CIK 0001579075 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,680,122 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.